Under the terms of the agreement, in addition to the license fee Roche will give Galaxy payments contingent on certain preclinical, clinical, and regulatory development benchmarks, as well as royalties on product sales. Galaxy has developed an antibody that neutralizes the biological activity...
FULL ARTICLE AT Aim West Milford